Benefit of Prompt Versus Delayed Initiation of Single-Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the US

home / publications / supplement / benefit-of-prompt-vs-delayed-initiation-of-trelegy-ellipta-fluticasone-furoate-umeclidinium-and-
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo